View in EDS

Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.

Saved in:
Bibliographic Details
Title: Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
Authors: Ortiz-Maldonado V; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Rives S; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain., Español-Rego M; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Alonso-Saladrigues A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Montoro M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain., Magnano L; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Giné E; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Pascal M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Díaz-Beyá M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Castella M; Banc de Sang i Teixits, Barcelona, Spain., Català A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain., Faura A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Rodríguez-Lobato LG; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Oliver-Caldes A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Martínez-Roca A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain., Rovira M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., González-Navarro EA; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Ortega JR; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Cid J; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Lozano M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Garcia-Rey E; Banc de Sang i Teixits, Barcelona, Spain., Fernández S; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Castro P; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Jordan I; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, Barcelona, Spain., Villamor N; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Aymerich M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Torrebadell M; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Laboratory of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Deyà À; Clinical Immunology and Primary Immunodeficiencies Unit, Hospital Sant Joan de Déu, Barcelona, Spain., Fernández de Larrea C; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Benitez-Ribas D; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Trias E; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Varea S; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain., Calvo G; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain., Esteve J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Urbano-Ispizua A; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Juan M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain jdelgado@clinic.cat mjuan@clinic.cat.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Clinical Immunology Platform, Hospital Clínic-Sant Joan de Déu, Barcelona, Spain., Delgado J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain jdelgado@clinic.cat mjuan@clinic.cat.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Dec; Vol. 9 (12).
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34907029
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Factors associated with the clinical outcome of patients with relapsed/refractory CD19<superscript>+</superscript> acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ortiz-Maldonado+V%22">Ortiz-Maldonado V</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rives+S%22">Rives S</searchLink>; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Español-Rego+M%22">Español-Rego M</searchLink>; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alonso-Saladrigues+A%22">Alonso-Saladrigues A</searchLink>; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Montoro+M%22">Montoro M</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Magnano+L%22">Magnano L</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Giné+E%22">Giné E</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pascal+M%22">Pascal M</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Díaz-Beyá+M%22">Díaz-Beyá M</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Castella+M%22">Castella M</searchLink>; Banc de Sang i Teixits, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Català+A%22">Català A</searchLink>; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Faura+A%22">Faura A</searchLink>; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Lobato+LG%22">Rodríguez-Lobato LG</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Oliver-Caldes+A%22">Oliver-Caldes A</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Roca+A%22">Martínez-Roca A</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rovira+M%22">Rovira M</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22González-Navarro+EA%22">González-Navarro EA</searchLink>; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ortega+JR%22">Ortega JR</searchLink>; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cid+J%22">Cid J</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lozano+M%22">Lozano M</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Rey+E%22">Garcia-Rey E</searchLink>; Banc de Sang i Teixits, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+S%22">Fernández S</searchLink>; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Castro+P%22">Castro P</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Jordan+I%22">Jordan I</searchLink>; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villamor+N%22">Villamor N</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Aymerich+M%22">Aymerich M</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Torrebadell+M%22">Torrebadell M</searchLink>; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Laboratory of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Deyà+À%22">Deyà À</searchLink>; Clinical Immunology and Primary Immunodeficiencies Unit, Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+de+Larrea+C%22">Fernández de Larrea C</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Benitez-Ribas+D%22">Benitez-Ribas D</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Trias+E%22">Trias E</searchLink>; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Varea+S%22">Varea S</searchLink>; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Calvo+G%22">Calvo G</searchLink>; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Esteve+J%22">Esteve J</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Urbano-Ispizua+A%22">Urbano-Ispizua A</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Juan+M%22">Juan M</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain jdelgado@clinic.cat mjuan@clinic.cat.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Clinical Immunology Platform, Hospital Clínic-Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Delgado+J%22">Delgado J</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain jdelgado@clinic.cat mjuan@clinic.cat.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2021 Dec; Vol. 9 (12).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34907029
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2021-003644
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ortiz-Maldonado V
      – PersonEntity:
          Name:
            NameFull: Rives S
      – PersonEntity:
          Name:
            NameFull: Español-Rego M
      – PersonEntity:
          Name:
            NameFull: Alonso-Saladrigues A
      – PersonEntity:
          Name:
            NameFull: Montoro M
      – PersonEntity:
          Name:
            NameFull: Magnano L
      – PersonEntity:
          Name:
            NameFull: Giné E
      – PersonEntity:
          Name:
            NameFull: Pascal M
      – PersonEntity:
          Name:
            NameFull: Díaz-Beyá M
      – PersonEntity:
          Name:
            NameFull: Castella M
      – PersonEntity:
          Name:
            NameFull: Català A
      – PersonEntity:
          Name:
            NameFull: Faura A
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Lobato LG
      – PersonEntity:
          Name:
            NameFull: Oliver-Caldes A
      – PersonEntity:
          Name:
            NameFull: Martínez-Roca A
      – PersonEntity:
          Name:
            NameFull: Rovira M
      – PersonEntity:
          Name:
            NameFull: González-Navarro EA
      – PersonEntity:
          Name:
            NameFull: Ortega JR
      – PersonEntity:
          Name:
            NameFull: Cid J
      – PersonEntity:
          Name:
            NameFull: Lozano M
      – PersonEntity:
          Name:
            NameFull: Garcia-Rey E
      – PersonEntity:
          Name:
            NameFull: Fernández S
      – PersonEntity:
          Name:
            NameFull: Castro P
      – PersonEntity:
          Name:
            NameFull: Jordan I
      – PersonEntity:
          Name:
            NameFull: Villamor N
      – PersonEntity:
          Name:
            NameFull: Aymerich M
      – PersonEntity:
          Name:
            NameFull: Torrebadell M
      – PersonEntity:
          Name:
            NameFull: Deyà À
      – PersonEntity:
          Name:
            NameFull: Fernández de Larrea C
      – PersonEntity:
          Name:
            NameFull: Benitez-Ribas D
      – PersonEntity:
          Name:
            NameFull: Trias E
      – PersonEntity:
          Name:
            NameFull: Varea S
      – PersonEntity:
          Name:
            NameFull: Calvo G
      – PersonEntity:
          Name:
            NameFull: Esteve J
      – PersonEntity:
          Name:
            NameFull: Urbano-Ispizua A
      – PersonEntity:
          Name:
            NameFull: Juan M
      – PersonEntity:
          Name:
            NameFull: Delgado J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2021 Dec
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1